Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Sun

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
The Journal of Biological Chemistry|June 3, 2017
Deletion of interleukin 1 receptor-associated kinase 1 (<i>Irak1</i>) improves glucose tolerance primarily by increasing insulin sensitivity in skeletal muscleXiao-Jian Sun, Soohyun Park Kim, Dongming Zhang, et al.
Progress in Community Health Partnerships : Research, Education, and Action|September 19, 2022
Establishing a National Engagement Strategy for Recruiting Asian Americans and Other Minorities into Biomedical ResearchFornessa T Randal, Siya Qi, Paula Lozano, et al.
European Urology Oncology|May 11, 2024
Assessing the Clinical Utility of Published Prostate Cancer Polygenic Risk Scores in a Large Biobank Data SetRandy A Vince, Helen Sun, Udit Singhal, et al.
American Journal of Surgery|March 17, 2024
Cardiovascular disease risk scores in patients with optimal vs suboptimal weight loss after bariatric surgery: Translating improvements into clinical practiceRajaa Mohamed Salih, Juan S Barajas-Gamboa, Gabriel Diaz Del Gobbo, et al.
Pharmacology Research & Perspectives|December 12, 2017
Identification of an antibody-based immunoassay for measuring direct target binding of RIPK1 inhibitors in cells and tissuesJoshua N Finger, Jean-Marie Brusq, Nino Campobasso, et al.
Journal of Medicinal Chemistry|April 24, 2019
Discovery and Lead-Optimization of 4,5-Dihydropyrazoles as Mono-Kinase Selective, Orally Bioavailable and Efficacious Inhibitors of Receptor Interacting Protein 1 (RIP1) KinasePhilip A Harris, Nicolas Faucher, Nicolas George, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
The Journal of Biological Chemistry|June 3, 2017
Deletion of interleukin 1 receptor-associated kinase 1 (<i>Irak1</i>) improves glucose tolerance primarily by increasing insulin sensitivity in skeletal muscleXiao-Jian Sun, Soohyun Park Kim, Dongming Zhang, et al.
Progress in Community Health Partnerships : Research, Education, and Action|September 19, 2022
Establishing a National Engagement Strategy for Recruiting Asian Americans and Other Minorities into Biomedical ResearchFornessa T Randal, Siya Qi, Paula Lozano, et al.
European Urology Oncology|May 11, 2024
Assessing the Clinical Utility of Published Prostate Cancer Polygenic Risk Scores in a Large Biobank Data SetRandy A Vince, Helen Sun, Udit Singhal, et al.
American Journal of Surgery|March 17, 2024
Cardiovascular disease risk scores in patients with optimal vs suboptimal weight loss after bariatric surgery: Translating improvements into clinical practiceRajaa Mohamed Salih, Juan S Barajas-Gamboa, Gabriel Diaz Del Gobbo, et al.
Pharmacology Research & Perspectives|December 12, 2017
Identification of an antibody-based immunoassay for measuring direct target binding of RIPK1 inhibitors in cells and tissuesJoshua N Finger, Jean-Marie Brusq, Nino Campobasso, et al.
Journal of Medicinal Chemistry|April 24, 2019
Discovery and Lead-Optimization of 4,5-Dihydropyrazoles as Mono-Kinase Selective, Orally Bioavailable and Efficacious Inhibitors of Receptor Interacting Protein 1 (RIP1) KinasePhilip A Harris, Nicolas Faucher, Nicolas George, et al.
Pageof 3